{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T13:44:44Z","timestamp":1784123084075,"version":"3.55.0"},"reference-count":94,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1097\/hco.0b013e32835fb7f3","type":"journal-article","created":{"date-parts":[[2013,4,2]],"date-time":"2013-04-02T15:45:54Z","timestamp":1364917554000},"page":"272-281","source":"Crossref","is-referenced-by-count":15,"title":["Genetics and sudden death"],"prefix":"10.1097","volume":"28","author":[{"given":"Raffaella","family":"Lombardi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210204","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1172\/JCI62928","article-title":"Molecular and genetic basis of sudden cardiac death.","volume":"123","author":"George","year":"2013","journal-title":"J Clin Invest"},{"key":"R3-3-20210204","first-page":"96","article-title":"Sudden death in the young: what do we know about it and how to prevent Circ Arrhythm E","volume":"3","author":"van der Werf","year":"2010","journal-title":"lectrophysiol"},{"key":"R4-3-20210204","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMra0902923","article-title":"Inherited cardiomyopathies.","volume":"364","author":"Watkins","year":"2011","journal-title":"N Engl J Med"},{"key":"R5-3-20210204","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1136\/hrt.2004.046334","article-title":"Genetics of cardiac arrhythmias.","volume":"91","author":"Wilde","year":"2005","journal-title":"Heart"},{"key":"R6-3-20210204","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1016\/S0140-6736(12)61413-5","article-title":"Ventricular arrhythmias and sudden cardiac death.","volume":"380","author":"John","year":"2012","journal-title":"Lancet"},{"key":"R7-3-20210204","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(12)61462-7","article-title":"Systems biology and cardiac arrhythmias.","volume":"380","author":"Grace","year":"2012","journal-title":"Lancet"},{"key":"R8-3-20210204","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.cell.2012.02.023","article-title":"Life in the fast lane: mammalian disease models in the genomics era.","volume":"148","author":"Dow","year":"2012","journal-title":"Cell"},{"key":"R9-3-20210204","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1083\/jcb.201207033","article-title":"Hypertrophic cardiomyopathy: translating cellular cross talk into therapeutics.","volume":"199","author":"Teekakirikul","year":"2012","journal-title":"J Cell Biol"},{"key":"R10-3-20210204","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.humpath.2006.03.008","article-title":"Sudden cardiac death in younger adults: autopsy diagnosis as a tool for preventive medicine.","volume":"37","author":"di Gioia","year":"2006","journal-title":"Hum Pathol"},{"key":"R11-3-20210204","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.carpath.2010.02.003","article-title":"Sudden cardiac death with normal heart: molecular autopsy.","volume":"19","author":"Basso","year":"2010","journal-title":"Cardiovasc Pathol"},{"key":"R12-3-20210204","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.mayocp.2012.02.017","article-title":"Cardiac channel molecular autopsy: insights from 173 consecutive cases of autopsy-negative sudden unexplained death referred for postmortem genetic testing.","volume":"87","author":"Tester","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"R13-3-20210204","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1161\/01.CIR.0000152479.54298.51","article-title":"Brugada syndrome: report of the Second Consensus Conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association.","volume":"111","author":"Antzelevitch","year":"2005","journal-title":"Circulation"},{"key":"R14-3-20210204","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.hrthm.2005.09.008","article-title":"Sudden death in the young.","volume":"2","author":"Puranik","year":"2005","journal-title":"Heart Rhythm"},{"key":"R15-3-20210204","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/nrcardio.2011.159","article-title":"Mechanisms of disease: hypertrophic cardiomyopathy.","volume":"9","author":"Frey","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"R16-3-20210204","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.ahj.2009.09.006","article-title":"Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations.","volume":"158","author":"McLeod","year":"2009","journal-title":"Am Heart J"},{"key":"R17-3-20210204","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/CIRCULATIONAHA.108.804617","article-title":"Sudden deaths in young competitive athletes: analysis of 1866 deaths in the United States, 1980-2006.","volume":"119","author":"Maron","year":"2009","journal-title":"Circulation"},{"key":"R18-3-20210204","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1365-2362.2010.02268.x","article-title":"Hypertrophic cardiomyopathy: from genetics to treatment.","volume":"40","author":"Marian","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"R19-3-20210204","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1161\/hc4601.097997","article-title":"Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy.","volume":"104","author":"Olivotto","year":"2001","journal-title":"Circulation"},{"key":"R20-3-20210204","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/CIRCULATIONAHA.105.583500","article-title":"Prevalence, clinical profile, and significance of left ventricular remodeling in the end-stage phase of hypertrophic cardiomyopathy.","volume":"114","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"R21-3-20210204","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1161\/01.RES.0000263008.66799.aa","article-title":"Myozenin 2 is a novel gene for human hypertrophic cardiomyopathy.","volume":"100","author":"Osio","year":"2007","journal-title":"Circ Res"},{"key":"R22-3-20210204","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/S0092-8674(02)01226-6","article-title":"The cardiac mechanical stretch sensor machinery involves a Z disc complex that is defective in a subset of human dilated cardiomyopathy.","volume":"111","author":"Knoll","year":"2002","journal-title":"Cell"},{"key":"R23-3-20210204","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1161\/CIRCRESAHA.112.270207","article-title":"Human molecular genetic and functional studies identify TRIM63, encoding muscle RING finger protein 1, as a novel gene for human hypertrophic cardiomyopathy.","volume":"111","author":"Chen","year":"2012","journal-title":"Circ Res"},{"key":"R24-3-20210204","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1093\/hmg\/ddm202","article-title":"Genome wide mapping of modifier chromosomal loci for human hypertrophic cardiomyopathy.","volume":"16","author":"Daw","year":"2007","journal-title":"Hum Mol Genet"},{"key":"R25-3-20210204","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.yjmcc.2004.02.010","article-title":"Evolution of expression of cardiac phenotypes over a 4-year period in the beta-myosin heavy chain-Q403 transgenic rabbit model of human hypertrophic cardiomyopathy.","volume":"36","author":"Nagueh","year":"2004","journal-title":"J Mol Cell Cardiol"},{"key":"R26-3-20210204","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1093\/cvr\/cvn078","article-title":"Differential interactions of thin filament proteins in two cardiac troponin T mouse models of hypertrophic and dilated cardiomyopathies.","volume":"79","author":"Lombardi","year":"2008","journal-title":"Cardiovasc Res"},{"key":"R27-3-20210204","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1016\/j.bpj.2012.04.049","article-title":"Cell intrinsic functional effects of the -cardiac myosin Arg-403-Gln mutation in familial hypertrophic cardiomyopathy.","volume":"102","author":"Chuan","year":"2012","journal-title":"Biophys J"},{"key":"R28-3-20210204","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/cvr\/cvs294","article-title":"Pathogenesis of hypertrophic cardiomyopathy caused by myozenin 2 mutations is independent of calcineurin activity.","volume":"97","author":"Ruggiero","year":"2013","journal-title":"Cardiovasc Res"},{"key":"R29-3-20210204","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1172\/JCI42028","article-title":"Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by nonmyocyte proliferation and requires Tgf.","volume":"120","author":"Teekakirikul","year":"2010","journal-title":"J Clin Invest"},{"key":"R30-3-20210204","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12265-009-9120-y","article-title":"Role of animal models in HCM research.","volume":"2","author":"Shephard","year":"2009","journal-title":"Cardiovasc Transl Res"},{"key":"R31-3-20210204","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1172\/JCI200214677","article-title":"The L-type calcium channel inhibitor diltiazem prevents cardiomyopathy in a mouse model.","volume":"109","author":"Semsarian","year":"2001","journal-title":"J Clin Invest"},{"key":"R32-3-20210204","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1161\/01.CIR.104.3.317","article-title":"Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy.","volume":"104","author":"Patel","year":"2001","journal-title":"Circulation"},{"key":"R33-3-20210204","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1161\/01.RES.0000177090.07296.ac","article-title":"Prevention of cardiac hypertrophy by atorvastatin in a transgenic rabbit model of human hypertrophic cardiomyopathy.","volume":"97","author":"Senthil","year":"2005","journal-title":"Circ Res"},{"key":"R34-3-20210204","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1161\/01.CIR.103.6.789","article-title":"Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy.","volume":"103","author":"Lim","year":"2001","journal-title":"Circulation"},{"key":"R35-3-20210204","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jacc.2005.10.041","article-title":"Antifibrotic effects of antioxidant N-acetylcysteine in a mouse model of human hypertrophic cardiomyopathy mutation.","volume":"47","author":"Marian","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R36-3-20210204","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1161\/CIRCULATIONAHA.108.790501","article-title":"Resolution of established cardiac hypertrophy and fibrosis and prevention of systolic dysfunction in a transgenic rabbit model of human cardiomyopathy through thiol-sensitive mechanisms.","volume":"119","author":"Lombardi","year":"2009","journal-title":"Circulation"},{"key":"R37-3-20210204","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/j.1365-2362.2007.01877.x","article-title":"HMG CoA reductase inhibition and left ventricular mass in hypertrophic cardiomyopathy: a randomized placebo-controlled pilot study.","volume":"37","author":"Bauersachs","year":"2007","journal-title":"Eur J Clin Invest"},{"key":"R38-3-20210204","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1111\/j.1365-2362.2010.02349.x","article-title":"Atorvastatin and cardiac hypertrophy and function in hypertrophic cardiomyopathy: a pilot study.","volume":"4011","author":"Nagueh","year":"2010","journal-title":"Eur J Clin Invest"},{"key":"R39-3-20210204","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1016\/j.amjcard.2005.07.065","article-title":"Effect of Losartan on left ventricular diastolic function in patients with nonobstructive hypertrophic cardiomyopathy.","volume":"96","author":"Araujo","year":"2005","journal-title":"Am J Cardiol"},{"key":"R40-3-20210204","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1536\/ihj.48.715","article-title":"A new therapeutic strategy for hypertrophic nonobstructive cardiomyopathy in humans. A randomized and prospective study with an Angiotensin II receptor blocker.","volume":"48","author":"Yamazaki","year":"2007","journal-title":"Int Heart J"},{"key":"R41-3-20210204","doi-asserted-by":"crossref","first-page":"2761","DOI":"10.1161\/CIR.0b013e318223e230","article-title":"2011 ACCFAHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology FoundationAmerican Heart Association Task Force on Practice Guidelines.","volume":"124","author":"Gersh","year":"2011","journal-title":"Circulation"},{"key":"R42-3-20210204","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/s00246-011-9890-2","article-title":"Molecular genetics and pathogenesis of arrhythmogenic right ventricular cardiomyopathy: a disease of cardiac stem cells.","volume":"32","author":"Lombardi","year":"2011","journal-title":"Pediatr Cardiol"},{"key":"R43-3-20210204","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1159\/000091640","article-title":"Sudden cardiac death in the young: a strategy for prevention by targeted evaluation.","volume":"105","author":"Sen-Chowdhry","year":"2006","journal-title":"Cardiology"},{"key":"R44-3-20210204","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1111\/j.1540-8167.2012.02412.x","article-title":"Arrhythmogenic right ventricular cardiomyopathy 2012: diagnostic challenges and treatment.","volume":"23","author":"Marcus","year":"2012","journal-title":"J Cardiovasc Electrophysiol"},{"key":"R45-3-20210204","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/S0140-6736(00)02379-5","article-title":"Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease).","volume":"355","author":"McKoy","year":"2000","journal-title":"Lancet"},{"key":"R46-3-20210204","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S1054-8807(03)00107-8","article-title":"Structural and molecular pathology of the heart in Carvajal syndrome.","volume":"13","author":"Kaplan","year":"2004","journal-title":"Cardiovasc Pathol"},{"key":"R47-3-20210204","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1086\/344208","article-title":"Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy.","volume":"71","author":"Rampazzo","year":"2002","journal-title":"Am J Hum Genet"},{"key":"R48-3-20210204","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1038\/ng1461","article-title":"Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy.","volume":"36","author":"Gerull","year":"2004","journal-title":"Nat Genet"},{"key":"R49-3-20210204","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1161\/CIRCULATIONAHA.105.609719","article-title":"Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasiacardiomyopathy.","volume":"113","author":"van Tintelen","year":"2006","journal-title":"Circulation"},{"key":"R50-3-20210204","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1161\/CIRCULATIONAHA.105.583674","article-title":"Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy.","volume":"113","author":"Pilichou","year":"2006","journal-title":"Circulation"},{"key":"R51-3-20210204","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1086\/509122","article-title":"Arrhythmogenic right ventricular dysplasiacardiomyopathy associated with mutations in the desmosomal gene desmocollin-2.","volume":"79","author":"Syrris","year":"2006","journal-title":"Am J Hum Genet"},{"key":"R52-3-20210204","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.cardiores.2004.10.005","article-title":"Regulatory mutations in transforming growth factor-beta 3 gene cause arrhythmogenic right ventricular cardiomyopathy type 1.","volume":"65","author":"Beffagna","year":"2005","journal-title":"Cardiovasc Res"},{"key":"R53-3-20210204","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ajhg.2008.01.010","article-title":"Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the tmem 43 gene.","volume":"82","author":"Merner","year":"2008","journal-title":"Am J Hum Genet"},{"key":"R54-3-20210204","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1172\/JCI27751","article-title":"Suppression of canonical Wntbeta-catenin signaling by nuclear plakoglobin recapitulates phenotype of arrhythmogenic right ventricular cardiomyopathy.","volume":"116","author":"Garcia-Gras","year":"2006","journal-title":"J Clin Invest"},{"key":"R55-3-20210204","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1161\/CIRCRESAHA.109.196899","article-title":"Genetic fate mapping identifies second heart field progenitor cells as a source of adipocytes in arrhythmogenic right ventricular cardiomyopathy.","volume":"104","author":"Lombardi","year":"2009","journal-title":"Circ Res"},{"key":"R56-3-20210204","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1161\/CIRCRESAHA.111.255075","article-title":"Nuclear plakoglobin is essential for differentiation of cardiac progenitor cells to adipocytes in arrhythmogenic right ventricular cardiomyopathy.","volume":"109","author":"Lombardi","year":"2011","journal-title":"Circ Res"},{"key":"R57-3-20210204","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/01.RES.0000241482.19382.c6","article-title":"Desmosomal dysfunction due to mutations in desmoplakin causes arrhythmogenic right ventricular dysplasiacardiomyopathy.","volume":"99","author":"Yang","year":"2006","journal-title":"Circ Res"},{"key":"R58-3-20210204","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/1471-2350-8-65","article-title":"Missense mutations in desmocollin-2 N-terminus, associated with arrhythmogenic right ventricular cardiomyopathy, affect intracellular localization of desmocollin-2 in vitro.","volume":"8","author":"Beffagna","year":"2007","journal-title":"BMC Med Genet"},{"key":"R59-3-20210204","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1084\/jem.20090641","article-title":"Myocyte necrosis underlies progressive myocardial dystrophy in mouse dsg2-related arrhythmogenic right ventricular cardiomyopathy.","volume":"206","author":"Pilichou","year":"2009","journal-title":"J Exp Med"},{"key":"R60-3-20210204","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.cellsig.2012.09.025","article-title":"Beyond cell adhesion: the role of armadillo proteins in the heart.","volume":"25","author":"Swope","year":"2013","journal-title":"Cell Signal"},{"key":"R61-3-20210204","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1126\/science.289.5481.950","article-title":"Inhibition of adipogenesis by Wnt signaling.","volume":"289","author":"Ross","year":"2000","journal-title":"Science"},{"key":"R62-3-20210204","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/cvr\/cvs219","article-title":"Intercalated disc abnormalities, reduced Na() current density, and conduction slowing in desmoglein-2 mutant mice prior to cardiomyopathic changes.","volume":"95","author":"Rizzo","year":"2012","journal-title":"Cardiovasc Res"},{"key":"R63-3-20210204","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1093\/cvr\/cvs218","article-title":"Sodium current deficit and arrhythmogenesis in a murine model of plakophilin-2 haploinsufficiency.","volume":"95","author":"Cerrone","year":"2012","journal-title":"Cardiovasc Res"},{"key":"R64-3-20210204","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1161\/CIRCRESAHA.107.154252","article-title":"Connexin 43 remodeling caused by inhibition of plakophilin-2 expression in cardiac cells.","volume":"101","author":"Oxford","year":"2007","journal-title":"Circ Res"},{"key":"R65-3-20210204","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1161\/CIRCRESAHA.109.201418","article-title":"Loss of plakophilin-2 expression leads to decreased sodium current and slower conduction velocity in cultured cardiac myocytes.","volume":"105","author":"Sato","year":"2009","journal-title":"Circ Res"},{"key":"R66-3-20210204","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1161\/01.CIR.0000103130.33451.D2","article-title":"Implantable cardioverter-defibrillator therapy for prevention of sudden death in patients with arrhythmogenic right ventricular cardiomyopathydysplasia.","volume":"108","author":"Corrado","year":"2003","journal-title":"Circulation"},{"key":"R67-3-20210204","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1016\/j.jacc.2011.01.015","article-title":"Update 2011: clinical and genetic issues in familial dilated cardiomyopathy.","volume":"57","author":"Hershberger","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R68-3-20210204","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1161\/CIRCULATIONAHA.106.174287","article-title":"Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.","volume":"113","author":"Maron","year":"2006","journal-title":"Circulation"},{"key":"R69-3-20210204","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1172\/JCI62862","article-title":"Genetic mutations and mechanisms in dilated cardiomyopathy.","volume":"123","author":"McNally","year":"2013","journal-title":"J Clin Invest"},{"key":"R70-3-20210204","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1093\/eurheartj\/ehr260","article-title":"Genetics of inherited cardiomyopathy.","volume":"33","author":"Jacoby","year":"2012","journal-title":"Eur Heart J"},{"key":"R71-3-20210204","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s000590050003","article-title":"The final common pathway hypothesis and inherited cardiovascular disease: the role of cytoskeletal proteins in dilated cardiomyopathy.","volume":"25","author":"Bowles","year":"2000","journal-title":"Herz"},{"key":"R72-3-20210204","doi-asserted-by":"crossref","first-page":"H284","DOI":"10.1152\/ajpheart.00128.2007","article-title":"Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay.","volume":"293","author":"Debold","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"R73-3-20210204","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1172\/JCI9224","article-title":"Mutations in the human delta-sarcoglycan gene in familial and sporadic dilated cardiomyopathy.","volume":"106","author":"Tsubata","year":"2000","journal-title":"J Clin Invest"},{"key":"R74-3-20210204","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.yjmcc.2009.11.013","article-title":"Titin-based regulations of diastolic and systolic functions of mammalian cardiac muscle.","volume":"48","author":"Fukuda","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"R75-3-20210204","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1073\/pnas.0510519103","article-title":"A mutation in the human phospholamban gene, deleting arginine 14, results in lethal, hereditary cardiomyopathy.","volume":"103","author":"Haghighi","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R76-3-20210204","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1172\/JCI200419670","article-title":"Lamin AC deficiency causes defective nuclear mechanics and mechanotransduction.","volume":"113","author":"Lammerding","year":"2004","journal-title":"J Clin Invest"},{"key":"R77-3-20210204","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/nrm3207","article-title":"The nucleoskeleton as a genome-associated dynamic network of networks.","volume":"12","author":"Simon","year":"2011","journal-title":"Nat Rev Mol Cell Biol"},{"key":"R78-3-20210204","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.hrthm.2011.10.016","article-title":"Genetic variation in the alternative splicing regulator RBM20 is associated with dilated cardiomyopathy.","volume":"9","author":"Refaat","year":"2012","journal-title":"Heart Rhythm"},{"key":"R79-3-20210204","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/cvr\/cvn301","article-title":"Energy metabolism in heart failure and remodelling.","volume":"81","author":"Ingwall","year":"2009","journal-title":"Cardiovasc Res"},{"key":"R80-3-20210204","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/CIRCEP.111.962019","article-title":"Long-QT syndrome: from genetics to management.","volume":"5","author":"Schwartz","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"R81-3-20210204","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.109.863209","article-title":"Prevalence of the congenital long-QT syndrome.","volume":"120","author":"Schwartz","year":"2009","journal-title":"Circulation"},{"key":"R82-3-20210204","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jacc.2006.10.010","article-title":"Postmortem long QT syndrome genetic testing for sudden unexplained death in the young.","volume":"49","author":"Tester","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"R83-3-20210204","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1161\/CIRCULATIONAHA.111.048041","article-title":"Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: implications for mutation-specific response to beta-blocker therapy in type-1 long-QT syndrome.","volume":"125","author":"Barsheshet","year":"2012","journal-title":"Circulation"},{"key":"R84-3-20210204","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1161\/CIRCRESAHA.110.224592","article-title":"Defining a new paradigm for human arrhythmia syndromes: phenotypic manifestations of gene mutations in ion channel- and transporter-associated proteins.","volume":"107","author":"Ackerman","year":"2010","journal-title":"Circ Res"},{"key":"R85-3-20210204","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1016\/j.hrthm.2010.06.013","article-title":"Long QT syndrome with compound mutations is associated with a more severe phenotype: a Japanese multicenter study.","volume":"7","author":"Itoh","year":"2010","journal-title":"Heart Rhythm"},{"key":"R86-3-20210204","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa0908679","article-title":"Patient-specific induced pluripotent stem-cell models for long-QT syndrome.","volume":"363","author":"Moretti","year":"2010","journal-title":"N Engl J Med"},{"key":"R87-3-20210204","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/nature09747","article-title":"Modelling the long QT syndrome with induced pluripotent stem cells.","volume":"471","author":"Itzhaki","year":"2011","journal-title":"Nature"},{"key":"R88-3-20210204","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1253\/circj.CJ-12-0717","article-title":"Brugada syndrome 2012.","volume":"76","author":"Berne","year":"2012","journal-title":"Circ J"},{"key":"R89-3-20210204","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.hrthm.2009.09.069","article-title":"An international compendium of mutations in the SCN5A-encoded cardiac sodium channel in patients referred for Brugada syndrome genetic testing.","volume":"7","author":"Kapplinger","year":"2010","journal-title":"Heart Rhythm"},{"key":"R90-3-20210204","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jacc.2011.08.064","article-title":"Risk stratification in Brugada syndrome: results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) registry.","volume":"59","author":"Priori","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"R91-3-20210204","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.hlc.2011.10.008","article-title":"Guidelines for the diagnosis and management of catecholaminergic polymorphic ventricular tachycardia.","volume":"21","author":"Pflaumer","year":"2012","journal-title":"Heart, Lung and Circ"},{"key":"R92-3-20210204","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1016\/j.jacc.2009.08.022","article-title":"The RYR2-encoded ryanodine receptorcalcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame mutational analysis.","volume":"54","author":"Medeiros-Domingo","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"R93-3-20210204","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nrcardio.2012.93","article-title":"Inherited calcium channelopathies in the pathophysiology of arrhythmias.","volume":"9","author":"Venetucci","year":"2012","journal-title":"Nat Rev Cardiol"},{"key":"R94-3-20210204","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.yjmcc.2010.10.001","article-title":"Calmodulin kinase II inhibition prevents arrhythmias in RyR2(R4496C) mice with catecholaminergic polymorphic ventricular tachycardia.","volume":"50","author":"Liu","year":"2011","journal-title":"J Mol Cell Cardiol"},{"key":"R95-3-20210204","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/emmm.201100194","article-title":"Dantrolene rescues arrhythmogenic RYR2 defect in a patient-specific stem cell model of catecholaminergic polymorphic ventricular tachycardia.","volume":"4","author":"Jung","year":"2012","journal-title":"EMBO Mol Med"}],"container-title":["Current Opinion in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/HCO.0b013e32835fb7f3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T00:54:27Z","timestamp":1620953667000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00001573-201305000-00003"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5]]},"references-count":94,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/hco.0b013e32835fb7f3","relation":{},"ISSN":["0268-4705"],"issn-type":[{"value":"0268-4705","type":"print"}],"subject":[],"published":{"date-parts":[[2013,5]]}}}